Jun 22, 2020
ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA
May 29, 2020
Data Affirming Biocept's Target Selector(TM) Platform Identifies Cancer Mutations in Cerebrospinal Fluid Presented at ASCO 2020 Virtual Scientific Program
Jan 22, 2020
Froedtert & the Medical College of Wisconsin Cancer Network Partners with UWM App Brewery for Brain Cancer Patients
Jan 14, 2020
Biocept Announces Validation and Availability of its Liquid Biopsy Platform for the Detection of Actionable Cancer Biomarkers in Cerebrospinal Fluid
Jun 03, 2019
New data on Vitrakvi® (larotrectinib) in TRK fusion cancer patients with brain metastases or primary central nervous system (CNS) tumors
Jun 03, 2019
Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019
May 20, 2019
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
May 15, 2019
Bayer presents new analyses for Vitrakvi® (larotrectinib) in adult and pediatric patients with TRK fusion cancer with solid tumors, and new data in primary central nervous system tumors and brain metastases
Apr 16, 2019
West Cancer Center Collaborates With Mayo Clinic on New Treatment for Pancreatic Cancer Patients
Nov 12, 2018
Monteris Medical Announces the Publication of Positive Clinical Data for Its NeuroBlate® Laser System for Patients with Brain Metastasis
May 22, 2018
Accuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study
Dec 28, 2017
Gamma Knife Market - Expected to Reach $239.2 Million by 2025
Dec 19, 2017
Study Finds Growing Socioeconomic and Racial Disparities in Management of Brain Metastases
Jun 22, 2017
First Patient in Canada Treated with Elekta's Leksell Gamma Knife Icon
May 26, 2017
Novartis receives FDA approval for expanded use of Zykadia® in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)